Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Evaluation of latent tuberculosis infection surveillance in Peel region, Ontario, 2010-2014.

Majerovich JA, Fernandes L, Varia M.

Can Commun Dis Rep. 2017 May 4;43(5):114-118. eCollection 2017 May 4.

2.

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.

Turajlic S, Xu H, Litchfield K, Rowan A, Horswell S, Chambers T, O'Brien T, Lopez JI, Watkins TBK, Nicol D, Stares M, Challacombe B, Hazell S, Chandra A, Mitchell TJ, Au L, Eichler-Jonsson C, Jabbar F, Soultati A, Chowdhury S, Rudman S, Lynch J, Fernando A, Stamp G, Nye E, Stewart A, Xing W, Smith JC, Escudero M, Huffman A, Matthews N, Elgar G, Phillimore B, Costa M, Begum S, Ward S, Salm M, Boeing S, Fisher R, Spain L, Navas C, Grönroos E, Hobor S, Sharma S, Aurangzeb I, Lall S, Polson A, Varia M, Horsfield C, Fotiadis N, Pickering L, Schwarz RF, Silva B, Herrero J, Luscombe NM, Jamal-Hanjani M, Rosenthal R, Birkbak NJ, Wilson GA, Pipek O, Ribli D, Krzystanek M, Csabai I, Szallasi Z, Gore M, McGranahan N, Van Loo P, Campbell P, Larkin J, Swanton C; TRACERx Renal Consortium.

Cell. 2018 Apr 19;173(3):595-610.e11. doi: 10.1016/j.cell.2018.03.043. Epub 2018 Apr 12.

3.

How Can We Keep Immigrant Travelers Healthy? Health Challenges Experienced by Canadian South Asian Travelers Visiting Friends and Relatives.

Savage RD, Rosella LC, Crowcroft NS, Arneja J, de Villa E, Horn M, Khan K, Varia M.

Qual Health Res. 2018 Mar;28(4):610-623. doi: 10.1177/1049732317746381. Epub 2017 Dec 14.

PMID:
29239271
4.

Technology and tuberculosis control: the OUT-TB Web experience.

Guthrie JL, Alexander DC, Marchand-Austin A, Lam K, Whelan M, Lee B, Furness C, Rea E, Stuart R, Lechner J, Varia M, McLean J, Jamieson FB.

J Am Med Inform Assoc. 2017 Apr 1;24(e1):e136-e142. doi: 10.1093/jamia/ocw130.

PMID:
27589943
5.

Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.

Lim K, Erickson B, Jürgenliemk-Schulz IM, Gaffney D, Creutzberg CL, Viswanathan A, Portelance L, Beriwal S, Wolfson A, Bosch W, De Los Santos J, Yashar C, Jhingran A, Varia M, El Naqa I, King B, Fyles A.

Pract Radiat Oncol. 2015 Nov-Dec;5(6):e557-65. doi: 10.1016/j.prro.2015.06.011. Epub 2015 Jul 2.

6.

Effect of race and histology on patterns of failure in women with early stage endometrial cancer treated with high dose rate brachytherapy.

Ozen A, Falchook AD, Varia MA, Gehrig P, Jones EL.

Gynecol Oncol. 2015 Aug;138(2):429-33. doi: 10.1016/j.ygyno.2015.05.025. Epub 2015 May 27.

PMID:
26024766
7.

ACR appropriateness Criteria® advanced stage endometrial cancer.

Elshaikh MA, Yashar CM, Wolfson AH, Cardenes HR, Erickson B, Jhingran A, Jolly S, Kidd E, Lee LJ, Mayr NA, Moore D, Rao GG, Small W Jr, Varia MA, Wahl AO, Yuh W, Gaffney DK; Expert Panel on Radiation Oncology-Gynecology:.

Am J Clin Oncol. 2014 Aug;37(4):391-6. doi: 10.1097/COC.0000000000000098.

PMID:
24977691
8.

Patterns of local failure for sinonasal malignancies.

Fried DV, Zanation AM, Huang B, Hayes N, Weissler M, Hackman T, Shores C, Rosenman J, Morris DE, Funkhouser W, Varia M, Chera BS.

Pract Radiat Oncol. 2013 Jul-Sep;3(3):e113-e120. doi: 10.1016/j.prro.2012.07.001. Epub 2012 Aug 9.

PMID:
24674372
9.

Acr appropriateness Criteria management of vaginal cancer.

Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W Jr, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney DK.

Oncology (Williston Park). 2013 Nov;27(11):1166-73. Review.

10.

ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva.

Expert Panel on Radiation Oncology-Gynecology, Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W Jr, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR.

Am J Clin Oncol. 2013 Aug;36(4):415-22. doi: 10.1097/COC.0b013e318295af1d. Review.

PMID:
23872794
11.

Hypoxia regulation of phosphokinases and the prognostic value of pAKT in breast cancer.

Wennemers M, Stegeman H, Bussink J, Versleijen-Jonkers YM, van Laarhoven HW, Raleigh JA, Varia MA, Sweep FC, Span PN.

Int J Biol Markers. 2013 Jun 28;28(2):151-60. doi: 10.5301/jbm.5000008.

PMID:
23558942
12.

Management of nonesthesioneuroblastoma sinonasal malignancies with neuroendocrine differentiation.

Fried D, Zanation AM, Huang B, Hayes N, Morris DE, Rosenman J, Varia M, Funkhouser W, Weissler M, Chera BS.

Laryngoscope. 2012 Oct;122(10):2210-5. doi: 10.1002/lary.23463. Epub 2012 Aug 9.

PMID:
22886723
13.

ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancer.

Small W Jr, Strauss JB, Jhingran A, Yashar CM, Cardenes HR, Erickson-Wittmann BA, Gullett N, Kidd E, Lee LJ, Mayr NA, Moore D, Puthawala AA, Rao GG, Varia MA, Wahl AO, Wolfson AH, Yuh W, Gaffney DK.

Am J Clin Oncol. 2012 Aug;35(4):399-405. doi: 10.1097/COC.0b013e3182610537. Review.

PMID:
22810416
14.

ACR Appropriateness Criteria® pretreatment planning of invasive cancer of the cervix.

Siegel CL, Andreotti RF, Cardenes HR, Brown DL, Gaffney DK, Horowitz NS, Javitt MC, Lee SI, Mitchell DG, Moore DH, Rao GG, Royal HD, Small W Jr, Varia MA, Yashar CM; American College of Radiology.

J Am Coll Radiol. 2012 Jun;9(6):395-402. doi: 10.1016/j.jacr.2012.02.021.

PMID:
22632665
15.

High grade serous carcinoma of the ovary with a yolk sac tumour component in a postmenopausal woman: report of an extremely rare phenomenon.

Varia M, McCluggage WG, Oommen R.

J Clin Pathol. 2012 Sep;65(9):853-4. doi: 10.1136/jclinpath-2011-200606. Epub 2012 Apr 11. No abstract available.

PMID:
22496516
16.

Perceived usefulness of syndromic surveillance in Ontario during the H1N1 pandemic.

Savage R, Chu A, Rosella LC, Crowcroft NS, Varia M, Policarpio ME, Vinson NG, Winter AL, Hay K, Davies RF, Gemmill I, Willison D, Johnson I.

J Public Health (Oxf). 2012 Jun;34(2):195-202. doi: 10.1093/pubmed/fdr088. Epub 2011 Dec 22.

PMID:
22194318
17.

ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancer.

Wolfson AH, Varia MA, Moore D, Rao GG, Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Small W Jr, Yashar CM, Yuh W, Cardenes HR; American College of Radiology (ACR).

Gynecol Oncol. 2012 Apr;125(1):256-62. doi: 10.1016/j.ygyno.2011.11.048. Epub 2011 Dec 7.

PMID:
22155418
18.

Endogenous myoglobin in breast cancer is hypoxia-inducible by alternative transcription and functions to impair mitochondrial activity: a role in tumor suppression?

Kristiansen G, Hu J, Wichmann D, Stiehl DP, Rose M, Gerhardt J, Bohnert A, ten Haaf A, Moch H, Raleigh J, Varia MA, Subarsky P, Scandurra FM, Gnaiger E, Gleixner E, Bicker A, Gassmann M, Hankeln T, Dahl E, Gorr TA.

J Biol Chem. 2011 Dec 16;286(50):43417-28. doi: 10.1074/jbc.M111.227553. Epub 2011 Sep 19.

19.

Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response.

Wennemers M, Bussink J, Scheijen B, Nagtegaal ID, van Laarhoven HW, Raleigh JA, Varia MA, Heuvel JJ, Rouschop KM, Sweep FC, Span PN.

Breast Cancer Res. 2011 Aug 24;13(4):R82. doi: 10.1186/bcr2934.

20.

ACR appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer of the uterus.

Lee JH, Dubinsky T, Andreotti RF, Cardenes HR, Dejesus Allison SO, Gaffney DK, Glanc P, Horowitz NS, Jhingran A, Lee SI, Puthawala AA, Royal HD, Scoutt LM, Small W Jr, Varia MA, Zelop CM; Expert Panel on Women's Imaging and Radiation Oncology-Gynecology.

Ultrasound Q. 2011 Jun;27(2):139-45. doi: 10.1097/RUQ.0b013e31821b6f73. Review.

PMID:
21606818
21.

Assessing secondary attack rates among household contacts at the beginning of the influenza A (H1N1) pandemic in Ontario, Canada, April-June 2009: a prospective, observational study.

Savage R, Whelan M, Johnson I, Rea E, LaFreniere M, Rosella LC, Lam F, Badiani T, Winter AL, Carr DJ, Frenette C, Horn M, Dooling K, Varia M, Holt AM, Sunil V, Grift C, Paget E, King M, Barbaro J, Crowcroft NS.

BMC Public Health. 2011 Apr 14;11:234. doi: 10.1186/1471-2458-11-234.

22.

Splay-bend elasticity of a nematic liquid crystal with T-shaped molecules.

Sathyanarayana P, Varia MC, Prajapati AK, Kundu B, Sastry VS, Dhara S.

Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Nov;82(5 Pt 1):050701. Epub 2010 Nov 10.

PMID:
21230425
23.

ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology-Gynecology.

Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Moore D, Rao GG, Small W Jr, Varia MA, Wolfson AH, Yashar CM, Yuh W, Cardenes HR.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):609-14. doi: 10.1016/j.ijrobp.2010.11.005. Epub 2011 Jan 5. No abstract available.

PMID:
21215531
24.

Stereotactic body radiotherapy (SBRT): Technological innovation and application in gynecologic oncology.

Higginson DS, Morris DE, Jones EL, Clarke-Pearson D, Varia MA.

Gynecol Oncol. 2011 Mar;120(3):404-12. doi: 10.1016/j.ygyno.2010.11.042. Epub 2010 Dec 30. Review.

PMID:
21194733
25.

Transmission of influenza A pandemic (H1N1) 2009 virus in a long-term care facility in Ontario, Canada.

Alexander DC, Winter AL, Eshaghi A, Dooling K, Frenette C, de Villa E, Varia M, Marchand-Austin A, Jamieson F, Gubbay JB.

Infect Control Hosp Epidemiol. 2010 Dec;31(12):1300-2. doi: 10.1086/657337. Epub 2010 Oct 28. No abstract available.

PMID:
21029007
26.

Response to Pothier et al. and Lowe on 'The NPTA may have underestimated tonsillectomy complications: a case note review of data submitted by two hospitals'.

McLaren RE, Gibbins NE, Varia ME, Lloyd RV, Shotton JS.

Clin Otolaryngol. 2009 Apr;34(2):166-7. doi: 10.1111/j.1749-4486.2009.01894.x. No abstract available.

PMID:
19413621
27.

Novel mesogenic azobenzene dimer at air-water and air-solid interfaces.

Kumar B, Prajapati AK, Varia MC, Suresh KA.

Langmuir. 2009 Jan 20;25(2):839-44. doi: 10.1021/la8030733.

PMID:
19099530
28.

Finding the gaps: an assessment of infection control surveillance needs in British Columbia acute care facilities.

Gamage B, Varia M, Litt M, Pugh S, Bryce E; PICNet Needs Assessment Working Group.

Am J Infect Control. 2008 Dec;36(10):706-10. doi: 10.1016/j.ajic.2008.06.004. Epub 2008 Oct 22.

PMID:
18945521
29.

Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.

Small W Jr, Mell LK, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, Jhingran A, Portelance L, Schefter T, Iyer R, Varia M, Winter K, Mundt AJ.

Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):428-34. Epub 2007 Nov 26.

30.

Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals.

Ofner-Agostini M, Varia M, Johnston L, Green K, Simor A, Amihod B, Bryce E, Henderson E, Stegenga J, Bergeron F; Canadian Nosocomial Infection Surveillance Program, Gravel D.

Am J Infect Control. 2007 Nov;35(9):563-8.

PMID:
17980232
31.

Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control.

Ewend MG, Brem S, Gilbert M, Goodkin R, Penar PL, Varia M, Cush S, Carey LA.

Clin Cancer Res. 2007 Jun 15;13(12):3637-41.

32.

Outbreak of acupuncture-associated cutaneous Mycobacterium abscessus infections.

Tang P, Walsh S, Murray C, Alterman C, Varia M, Broukhanski G, Chedore P, DeKoven J, Assaad D, Gold WL, Ghazarian D, Finkelstein M, Pritchard M, Yaffe B, Jamieson F, Henry B, Phillips E.

J Cutan Med Surg. 2006 Jul-Aug;10(4):166-9.

PMID:
17234114
33.

ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth.

Bi M, Naczki C, Koritzinsky M, Fels D, Blais J, Hu N, Harding H, Novoa I, Varia M, Raleigh J, Scheuner D, Kaufman RJ, Bell J, Ron D, Wouters BG, Koumenis C.

EMBO J. 2005 Oct 5;24(19):3470-81. Epub 2005 Sep 8.

34.

West Nile Virus: the buzz on Ottawa residents' awareness, attitudes and practices.

Wilson SD, Varia M, Lior LY; Field Epidemiology Summer Course.

Can J Public Health. 2005 Mar-Apr;96(2):109-13.

PMID:
15850029
35.

Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia.

Arcasoy MO, Amin K, Chou SC, Haroon ZA, Varia M, Raleigh JA.

Clin Cancer Res. 2005 Jan 1;11(1):20-7.

36.

Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.

Nag S, Cardenes H, Chang S, Das IJ, Erickson B, Ibbott GS, Lowenstein J, Roll J, Thomadsen B, Varia M; Image-Guided Brachytherapy Working Group.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1160-72.

PMID:
15519788
37.
38.

Hypoxia and differentiation in squamous cell carcinomas of the uterine cervix: pimonidazole and involucrin.

Azuma Y, Chou SC, Lininger RA, Murphy BJ, Varia MA, Raleigh JA.

Clin Cancer Res. 2003 Oct 15;9(13):4944-52.

39.

Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada.

Varia M, Wilson S, Sarwal S, McGeer A, Gournis E, Galanis E, Henry B; Hospital Outbreak Investigation Team.

CMAJ. 2003 Aug 19;169(4):285-92.

40.

Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.

Varia MA, Stehman FB, Bundy BN, Benda JA, Clarke-Pearson DL, Alvarez RD, Long HJ; Gynecologic Oncology Group.

J Clin Oncol. 2003 Aug 1;21(15):2849-55.

PMID:
12885800
41.

Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas.

Nordsmark M, Loncaster J, Aquino-Parsons C, Chou SC, Ladekarl M, Havsteen H, Lindegaard JC, Davidson SE, Varia M, West C, Hunter R, Overgaard J, Raleigh JA.

Radiother Oncol. 2003 Apr;67(1):35-44.

PMID:
12758238
42.

Clinical applications of proton MR spectroscopy in oncology.

Kwock L, Smith JK, Castillo M, Ewend MG, Cush S, Hensing T, Varia M, Morris D, Bouldin TW.

Technol Cancer Res Treat. 2002 Feb;1(1):17-28. Review.

PMID:
12614173
43.

HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.

Janssen HL, Haustermans KM, Sprong D, Blommestijn G, Hofland I, Hoebers FJ, Blijweert E, Raleigh JA, Semenza GL, Varia MA, Balm AJ, van Velthuysen ML, Delaere P, Sciot R, Begg AC.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1537-49.

PMID:
12459383
44.

Functional significance of erythropoietin receptor expression in breast cancer.

Arcasoy MO, Amin K, Karayal AF, Chou SC, Raleigh JA, Varia MA, Haroon ZA.

Lab Invest. 2002 Jul;82(7):911-8.

PMID:
12118093
45.

Hypoxia and perfusion measurements in human tumors--initial experience with pimonidazole and IUdR.

Begg AC, Janssen H, Sprong D, Hofland I, Blommestijn G, Raleigh JA, Varia M, Balm A, Van Velthuyzen L, Delaere P, Sciot R, Haustermans KMG.

Acta Oncol. 2001;40(8):924-8.

PMID:
11845956
46.

Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.

Nordsmark M, Loncaster J, Chou SC, Havsteen H, Lindegaard JC, Davidson SE, Varia M, West C, Hunter R, Overgaard J, Raleigh JA.

Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):581-6.

PMID:
11173158
47.

Semiquantitative immunohistochemical analysis for hypoxia in human tumors.

Raleigh JA, Chou SC, Bono EL, Thrall DE, Varia MA.

Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):569-74.

PMID:
11173156
48.

The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium.

Nag S, Erickson B, Parikh S, Gupta N, Varia M, Glasgow G.

Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):779-90.

PMID:
11020575
49.

Diffusion limited hypoxia estimated by vascular image analysis: comparison with pimonidazole staining in human tumors.

Haustermans K, Hofland I, Van de Pavert L, Geboes K, Varia M, Raleigh J, Begg AC.

Radiother Oncol. 2000 Jun;55(3):325-33.

PMID:
10869747
50.

Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas.

Quattrocchi KB, Miller CH, Cush S, Bernard SA, Dull ST, Smith M, Gudeman S, Varia MA.

J Neurooncol. 1999;45(2):141-57.

PMID:
10778730

Supplemental Content

Support Center